VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.


Autoria(s): Petrova T.V.; Bono P.; Holnthoner W.; Chesnes J.; Pytowski B.; Sihto H.; Laakkonen P.; Heikkilä P.; Joensuu H.; Alitalo K.
Data(s)

2008

Identificador

http://serval.unil.ch/?id=serval:BIB_3C531F3FBC5B

isbn:1878-3686 (Electronic)

pmid:18538738

doi:10.1016/j.ccr.2008.04.022

isiid:000256727900011

Idioma(s)

en

Fonte

Cancer Cell, vol. 13, no. 6, pp. 554-556

Palavras-Chave #Antibodies; Antibody Specificity; Blood Vessels/chemistry; Blood Vessels/pathology; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Separation; Endothelial Cells/chemistry; Flow Cytometry; Humans; Immunohistochemistry/methods; Lymphatic Vessels/chemistry; Lymphatic Vessels/pathology; Neoplasms/blood supply; Neoplasms/chemistry; RNA, Messenger/analysis; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor Receptor-3/analysis; Vascular Endothelial Growth Factor Receptor-3/genetics
Tipo

info:eu-repo/semantics/article

article